News
Cipla and Roche tie-up to sell 2 cancer drugs in India
The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India. This...
News
José Baselga, Named as Bristol-Myers Squibb’s M.D., Ph.D. to Board of Directors
Bristol-Myers Squibb Company announced that its Board of Directors has elected José Baselga, M.D., Ph.D., to the Board, effective March 1, 2018. Dr. Baselga...
Industry Reports
Sessa Capital Im LP decline Its Bristol Myers Squibb Co (BMY) Position by $272.76 Million
Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It is positive, as 62 investors sold BMY shares...
Press Releases
Biogen, AbbVie draw Multiple Sclerosis Drug On Inflammation Reports
RBC analyst Brian Abrahams said the decision will have "zero material impact" on Biogen as Zinbryta was expected to bring in about $400 million...
News
Novartis shareholders grant all resolutions projected by Board of Directors at the Annual General Meeting
Novartis shareholders today agreed to the Board of Directors' recommendations for all proposed resolutions at the Group's Annual General Meeting (AGM). A total of...
Press Releases
Pfizer gets optimistic response from CHMP for its CHEMOTHERAPY and MYELOGENOUS LEUKEMIA
Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted positive opinions recommending that two Pfizer...
Packaging & Labelling
Gore to Debut GORE™ ImproJect™ Plunger for Sensitive Biologics in Pre-Filled Syringes
W.L. Gore & Associates, Inc. (“Gore”), a global materials science company, will introduce its new GORE™ ImproJect™ Plunger at Pharmapack 2018, Europe's dedicated pharmaceutical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read